Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Diabetic and Non- Diabetic Lupus Nephritis Patients

NCT05704088 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT05704088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05704088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Diabetic and Non- Diabetic Lupus Nephritis Patients
Lead sponsor
Mansoura University
Phase
Phase 4
Overall status
Completed
Start date
October 8, 2022
Completion date
January 8, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bmd, lupus nephritis, sglt2 inhibitors